Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research and Treatment
Published in: Breast Cancer Research and Treatment 1/2018

01-01-2018 | Epidemiology

Healthy lifestyle impact on breast cancer-specific and all-cause mortality

Authors: Adaline E. Heitz, Richard N. Baumgartner, Kathy B. Baumgartner, Stephanie D. Boone

Published in: Breast Cancer Research and Treatment | Issue 1/2018

Login to get access

Abstract

Purpose

While several studies have evaluated the association of combined lifestyle factors on breast cancer-specific mortality, few have included Hispanic women. We constructed a “healthy behavior index” (HBI) and evaluated its associations with mortality in non-Hispanic White (NHW) and Hispanic women diagnosed with breast cancer from the southwestern U.S.

Methods

Diet and lifestyle questionnaires were analyzed for 837 women diagnosed with invasive breast cancer (1999–2004) in New Mexico as part of the 4-Corners Women’s Health Study. An HBI score ranging from 0 to 12 was based on dietary pattern, physical activity, smoking, alcohol consumption, and body size and shape, with increasing scores representing less healthy characteristics. Hazard ratios for mortality over 14 years of follow-up were estimated for HBI quartiles using Cox proportional hazards models adjusting for education and stratified by ethnicity and stage at diagnosis.

Results

A significant increasing trend was observed across HBI quartiles among all women, NHW women, and those diagnosed with localized or regional/distant stage of disease for all-cause (AC) mortality (p-trend = 0.006, 0.002, 0.03, respectively). AC mortality was increased >2-fold for all women and NHW women in HBI Q4 versus Q1 (HR = 2.18, 2.65, respectively). The association was stronger in women with regional/distant than localized stage of disease (HR = 2.62, 1.94, respectively). Associations for Hispanics or breast cancer-specific mortality were not significant.

Conclusions

These findings indicate the associations between the HBI and AC mortality, which appear to differ by ethnicity and stage at diagnosis. Interventions for breast cancer survivors should address the combination of lifestyle factors on prognosis.
Literature
1.
2.
3.
Saxe GA et al (1999) Diet and risk for breast cancer recurrence and survival. Breast Cancer Res Treat 53(3):241–253CrossRefPubMed
4.
Jain M, Miller AB (1997) Tumor characteristics and survival of breast cancer patients in relation to premorbid diet and body size. Breast Cancer Res Treat 42(1):43–55CrossRefPubMed
5.
Hebert JR, Hurley TG, Ma Y (1998) The effect of dietary exposures on recurrence and mortality in early stage breast cancer. Breast Cancer Res Treat 51(1):17–28CrossRefPubMed
6.
Boone SD et al (2015) Active and passive cigarette smoking and mortality among Hispanic and non-Hispanic white women diagnosed with invasive breast cancer. Ann Epidemiol 25(11):824–831CrossRefPubMedPubMedCentral
7.
Pierce JP et al (2014) Lifetime cigarette smoking and breast cancer prognosis in the After Breast Cancer Pooling Project. J Natl Cancer Inst. 106(1):djt359CrossRefPubMed
8.
Passarelli MN et al (2016) Cigarette smoking before and after breast cancer diagnosis: mortality from breast cancer and smoking-related diseases. J Clin Oncol 34(12):1315–1322CrossRefPubMedPubMedCentral
9.
Holmes MD et al (2005) Physical activity and survival after breast cancer diagnosis. JAMA 293(20):2479–2486CrossRefPubMed
10.
Holick CN et al (2008) Physical activity and survival after diagnosis of invasive breast cancer. Cancer Epidemiol Biomarkers Prev 17(2):379–386CrossRefPubMed
11.
Irwin ML et al (2008) Influence of pre- and postdiagnosis physical activity on mortality in breast cancer survivors: the health, eating, activity, and lifestyle study. J Clin Oncol 26(24):3958–3964CrossRefPubMedPubMedCentral
12.
Feigelson HS et al (2001) Alcohol consumption increases the risk of fatal breast cancer (United States). Cancer Causes Control 12(10):895–902CrossRefPubMed
13.
Kwan ML et al (2013) Postdiagnosis alcohol consumption and breast cancer prognosis in the after breast cancer pooling project. Cancer Epidemiol Biomarkers Prev 22(1):32–41CrossRefPubMed
14.
Kwan ML et al (2010) Alcohol consumption and breast cancer recurrence and survival among women with early-stage breast cancer: the life after cancer epidemiology study. J Clin Oncol 28(29):4410–4416CrossRefPubMedPubMedCentral
15.
Dal Maso L et al (2008) Effect of obesity and other lifestyle factors on mortality in women with breast cancer. Int J Cancer 123(9):2188–2194CrossRef
16.
Connor AE et al (2013) Obesity and risk of breast cancer mortality in Hispanic and Non-Hispanic white women: the New Mexico Women’s Health Study. J Womens Health (Larchmt) 22(4):368–377CrossRef
17.
Borugian MJ et al (2003) Waist-to-hip ratio and breast cancer mortality. Am J Epidemiol 158(10):963–968CrossRefPubMed
18.
Kushi LH et al (2012) American Cancer Society Guidelines on nutrition and physical activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J Clin 62(1):30–67CrossRefPubMed
19.
20.
Thomson CA et al (2014) Nutrition and physical activity cancer prevention guidelines, cancer risk, and mortality in the women’s health initiative. Cancer Prev Res 7(1):42–53CrossRef
21.
Kabat GC et al (2015) Adherence to cancer prevention guidelines and cancer incidence, cancer mortality, and total mortality: a prospective cohort study. Am J Clin Nutr 101(3):558–569CrossRefPubMedPubMedCentral
22.
Hastert TA et al (2014) Adherence to the WCRF/AICR cancer prevention recommendations and cancer-specific mortality: results from the Vitamins and Lifestyle (VITAL) Study. Cancer Causes Control 25(5):541–552CrossRefPubMedPubMedCentral
23.
Makarem N et al (2015) Concordance with World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) guidelines for cancer prevention and obesity-related cancer risk in the Framingham Offspring cohort (1991–2008). Cancer Causes Control 26(2):277–286CrossRefPubMedPubMedCentral
24.
Harris HR, Bergkvist L, Wolk A (2016) Adherence to the World Cancer Research Fund/American Institute for Cancer Research recommendations and breast cancer risk. Int J Cancer 138(11):2657–2664CrossRefPubMed
25.
Catsburg C, Miller AB, Rohan TE (2014) Adherence to cancer prevention guidelines and risk of breast cancer. Int J Cancer 135(10):2444–2452CrossRefPubMed
26.
Romaguera D et al (2012) Is concordance with World Cancer Research Fund/American Institute for Cancer Research guidelines for cancer prevention related to subsequent risk of cancer? Results from the EPIC study. Am J Clin Nutr 96(1):150–163CrossRefPubMed
27.
Nomura SJ et al (2016) WCRF/AICR recommendation adherence and breast cancer incidence among postmenopausal women with and without non-modifiable risk factors. Int J Cancer 138(11):2602–2615CrossRefPubMedPubMedCentral
28.
Khaw KT et al (2008) Combined impact of health behaviours and mortality in men and women: the EPIC-Norfolk prospective population study. PLoS Med 5(1):e12CrossRefPubMedPubMedCentral
29.
McCullough ML et al (2011) Following cancer prevention guidelines reduces risk of cancer, cardiovascular disease, and all-cause mortality. Cancer Epidemiol Biomarkers Prev 20(6):1089–1097CrossRefPubMed
30.
Petersen KE et al (2015) The combined impact of adherence to five lifestyle factors on all-cause, cancer and cardiovascular mortality: a prospective cohort study among Danish men and women. Br J Nutr 113(5):849–858CrossRefPubMed
31.
32.
Simpson ER, Brown KA (2013) Obesity and breast cancer: role of inflammation and aromatase. J Mol Endocrinol 51(3):T51–T59CrossRefPubMed
33.
Slattery ML et al (2014) Diet and lifestyle factors modify immune/inflammation response genes to alter breast cancer risk and prognosis: the Breast Cancer Health Disparities Study. Mutat Res 770:19–28CrossRefPubMedPubMedCentral
34.
Malik S et al (2004) Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 110(10):1245–1250CrossRefPubMed
35.
Mozaffarian D (2015) Nutrition and cardiovascular and metabolic disease. In: Bonow RO, Mann DL, Zipes DP, Libby P (eds) Braunwald’s heart disease: a textbook of cardiovascular medicine. Elsevier Saunders, Philadelphia
36.
Benowitz NL (2003) Cigarette smoking and cardiovascular disease: pathophysiology and implications for treatment. Prog Cardiovasc Dis 46(1):91–111CrossRefPubMed
37.
Boone SD et al (2014) The joint contribution of tumor phenotype and education to breast cancer survival disparity between Hispanic and non-Hispanic white women. Cancer Causes Control 25(3):273–282CrossRefPubMed
38.
39.
Li CI, Malone KE, Daling JR (2003) Differences in breast cancer stage, treatment, and survival by race and ethnicity. Arch Intern Med 163(1):49–56CrossRefPubMed
40.
Hines LM et al (2011) Ethnic disparities in breast tumor phenotypic subtypes in Hispanic and non-Hispanic white women. J Womens Health 20(10):1543–1550CrossRef
41.
Connor AE et al (2013) Differences between Hispanic and non-Hispanic white women with breast cancer for clinical characteristics and their correlates. Ann Epidemiol 23(4):227–232CrossRefPubMedPubMedCentral
42.
Banegas MP, Li CI (2012) Breast cancer characteristics and outcomes among Hispanic Black and Hispanic White women. Breast Cancer Res Treat 134(3):1297–1304CrossRefPubMedPubMedCentral
43.
Slattery ML et al (2007) Body size, weight change, fat distribution and breast cancer risk in Hispanic and non-Hispanic white women. Breast Cancer Res Treat 102(1):85–101CrossRefPubMed
44.
Sweeney C et al (2007) Recruiting Hispanic women for a population-based study: validity of surname search and characteristics of nonparticipants. Am J Epidemiol 166(10):1210–1219CrossRefPubMed
45.
Murtaugh MA et al (2007) Diet composition and risk of overweight and obesity in women living in the southwestern United States. J Am Diet Assoc 107(8):1311–1321CrossRefPubMed
46.
WHO (1992) International statistical classification of diseases and related health problems (10th Revision). World Health Organization, Geneva
47.
Hoyert DL (2012) 75 years of mortality in the United States, 1935–2010. NCHS Data Brief 88:1–8
48.
49.
Kromhout D et al (2002) Prevention of coronary heart disease by diet and lifestyle: evidence from prospective cross-cultural, cohort, and intervention studies. Circulation 105(7):893–898CrossRefPubMed
50.
Vergnaud AC et al (2013) Adherence to the World Cancer Research Fund/American Institute for Cancer Research guidelines and risk of death in Europe: results from the European Prospective Investigation into Nutrition and Cancer cohort study 1,4. Am J Clin Nutr 97(5):1107–1120CrossRefPubMed
51.
Grann V et al (2006) Regional and racial disparities in breast cancer-specific mortality. Soc Sci Med 62(2):337–347CrossRefPubMed
52.
Komenaka IK et al (2010) Race and ethnicity and breast cancer outcomes in an underinsured population. J Natl Cancer Inst 102(15):1178–1187CrossRefPubMed
53.
54.
Harper S et al (2009) Trends in area-socioeconomic and race-ethnic disparities in breast cancer incidence, stage at diagnosis, screening, mortality, and survival among women ages 50 years and over (1987–2005). Cancer Epidemiol Biomarkers Prev 18(1):121–131CrossRefPubMed
55.
Gonzalez EC et al (2001) Comorbid illness and the early detection of cancer. South Med J 94(9):913–920CrossRefPubMed
56.
57.
58.
Darby SC et al (2013) Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med 368(11):987–998CrossRefPubMed
59.
Swain SM, Whaley FS, Ewer MS (2003) Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials. Cancer 97(11):2869–2879CrossRefPubMed
60.
Grossmann ME et al (2010) Obesity and breast cancer: status of leptin and adiponectin in pathological processes. Cancer Metastasis Rev 29(4):641–653CrossRefPubMed
61.
Lautenbach A et al (2009) Obesity and the associated mediators leptin, estrogen and IGF-I enhance the cell proliferation and early tumorigenesis of breast cancer cells. Nutr Cancer 61(4):484–491CrossRefPubMed
62.
Cleary MP (2013) Impact of obesity on development and progression of mammary tumors in preclinical models of breast cancer. J Mammary Gland Biol Neoplasia 18(3–4):333–343CrossRefPubMedPubMedCentral
63.
Rock CL, Demark-Wahnefried W (2002) Nutrition and survival after the diagnosis of breast cancer: a review of the evidence. J Clin Oncol 20(15):3302–3316CrossRefPubMedPubMedCentral
64.
McTiernan A et al (2004) Effect of exercise on serum estrogens in postmenopausal women: a 12-month randomized clinical trial. Cancer Res 64(8):2923–2928CrossRefPubMed
65.
McTiernan A et al (1998) Physical activity and cancer etiology: associations and mechanisms. Cancer Causes Control 9(5):487–509CrossRefPubMed
66.
Chlebowski RT et al (2004) Insulin, physical activity, and caloric intake in postmenopausal women: breast cancer implications. J Clin Oncol 22(22):4507–4513CrossRefPubMed
67.
Kaaks R, Lukanova A (2001) Energy balance and cancer: the role of insulin and insulin-like growth factor-I. Proc Nutr Soc 60(1):91–106CrossRefPubMed
68.
He K et al (2004) Changes in intake of fruits and vegetables in relation to risk of obesity and weight gain among middle-aged women. Int J Obes Relat Metab Disord 28(12):1569–1574CrossRefPubMed
69.
70.
Fink BN et al (2007) Dietary flavonoid intake and breast cancer survival among women on Long Island. Cancer Epidemiol Biomarkers Prev 16(11):2285–2292CrossRefPubMed
71.
Lauber SN, Gooderham NJ (2011) The cooked meat-derived mammary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine promotes invasive behaviour of breast cancer cells. Toxicology 279(1–3):139–145CrossRefPubMed
72.
Papaioannou MD, Koufaris C, Gooderham NJ (2014) The cooked meat-derived mammary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) elicits estrogenic-like microRNA responses in breast cancer cells. Toxicol Lett 229(1):9–16CrossRefPubMed
73.
Purohit V (1998) Moderate alcohol consumption and estrogen levels in postmenopausal women: a review. Alcohol Clin Exp Res 22(5):994–997CrossRefPubMed
74.
Endogenous H et al (2011) Circulating sex hormones and breast cancer risk factors in postmenopausal women: reanalysis of 13 studies. Br J Cancer 105(5):709–722CrossRef
75.
Eliassen AH, Hankinson SE (2008) Endogenous hormone levels and risk of breast, endometrial and ovarian cancers: prospective studies. Adv Exp Med Biol 630:148–165CrossRefPubMed
76.
Gu JW et al (2005) Ethanol stimulates tumor progression and expression of vascular endothelial growth factor in chick embryos. Cancer 103(2):422–431CrossRefPubMed
77.
United States. Public Health Service. Office of the Surgeon General., How tobacco smoke causes disease: the biology and behavioral basis for smoking-attributable disease: a report of the Surgeon General. 2010, Rockville, MD. Washington, DC: U.S. Dept. of Health and Human Services, Public Health Service. p. 704
78.
Daniell HW (1988) Increased lymph node metastases at mastectomy for breast cancer associated with host obesity, cigarette smoking, age, and large tumor size. Cancer 62(2):429–435CrossRefPubMed
79.
Murin S, Inciardi J (2001) Cigarette smoking and the risk of pulmonary metastasis from breast cancer. Chest 119(6):1635–1640CrossRefPubMed
80.
Manjer J et al (2001) Smoking associated with hormone receptor negative breast cancer. Int J Cancer 91(4):580–584CrossRefPubMed
81.
Lesser GT, Deutsch S (1967) Measurement of adipose tissue blood flow and perfusion in man by uptake of 85Kr. J Appl Physiol 23(5):621–630CrossRefPubMed
82.
Collis T et al (2001) Relations of stroke volume and cardiac output to body composition: the strong heart study. Circulation 103(6):820–825CrossRefPubMed
83.
Mathew B et al (2008) Obesity: effects on cardiovascular disease and its diagnosis. J Am Board Fam Med 21(6):562–568CrossRefPubMed
84.
Shamsuzzaman AS et al (2002) Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation 105(21):2462–2464CrossRefPubMed
85.
Lundgren CH et al (1996) Elaboration of type-1 plasminogen activator inhibitor from adipocytes. A potential pathogenetic link between obesity and cardiovascular disease. Circulation 93(1):106–110CrossRefPubMed
86.
87.
88.
Thijssen DH et al (2010) Impact of inactivity and exercise on the vasculature in humans. Eur J Appl Physiol 108(5):845–875CrossRefPubMed
89.
Jacobs DR Jr, Tapsell LC (2007) Food, not nutrients, is the fundamental unit in nutrition. Nutr Rev 65(10):439–450PubMed
90.
Mozaffarian D, Ludwig DS (2010) Dietary guidelines in the 21st century–a time for food. JAMA 304(6):681–682CrossRefPubMed
91.
Mozaffarian D, Appel LJ, Van Horn L (2011) Components of a cardioprotective diet: new insights. Circulation 123(24):2870–2891CrossRefPubMed
92.
Bradley KA, Donovan DM, Larson EB (1993) How much is too much? Advising patients about safe levels of alcohol consumption. Arch Intern Med 153(24):2734–2740CrossRefPubMed
93.
Klatsky AL et al (1977) Alcohol consumption and blood pressure Kaiser-Permanente multiphasic health examination data. N Engl J Med 296(21):1194–1200CrossRefPubMed
94.
95.
Stampfer MJ et al (1988) A prospective study of moderate alcohol consumption and the risk of coronary disease and stroke in women. N Engl J Med 319(5):267–273CrossRefPubMed
96.
97.
Ambrose JA, Barua RS (2004) The pathophysiology of cigarette smoking and cardiovascular disease: an update. J Am Coll Cardiol 43(10):1731–1737CrossRefPubMed
98.
Craig WY, Palomaki GE, Haddow JE (1989) Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data. BMJ 298(6676):784–788CrossRefPubMedPubMedCentral
99.
Reaven G, Tsao PS (2003) Insulin resistance and compensatory hyperinsulinemia: the key player between cigarette smoking and cardiovascular disease? J Am Coll Cardiol 41(6):1044–1047CrossRefPubMed
Metadata
Title
Healthy lifestyle impact on breast cancer-specific and all-cause mortality
Authors
Adaline E. Heitz
Richard N. Baumgartner
Kathy B. Baumgartner
Stephanie D. Boone
Publication date
01-01-2018
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 1/2018
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-017-4467-2

Other articles of this Issue 1/2018

Breast Cancer Research and Treatment 1/2018 Go to the issue

Epidemiology

Obesity, physical activity, and breast cancer survival among older breast cancer survivors in the Cancer Prevention Study-II Nutrition Cohort

Epidemiology

Concordance analysis of paired cancer antigen (CA) 15-3 and 27.29 testing

Epidemiology

Association of the severity of diabetes-related complications with stage of breast cancer at diagnosis among elderly women with pre-existing diabetes

Review

Molecular profile of atypical hyperplasia of the breast

Epidemiology

Weight gain in hormone receptor-positive (HR+) early-stage breast cancer: is it menopausal status or something else?

Clinical trial

Immunohistochemical versus molecular (BluePrint and MammaPrint) subtyping of breast carcinoma. Outcome results from the EORTC 10041/BIG 3-04 MINDACT trial
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits